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P27, P16
CDKIs encoders. Related
to cell cycle control. P16 
participates in RB pathway.
P27 expression.
Genetic and epigenetic 
alterations in P16.
P53
Same as in canine 
mastocitoma.





Expression    tumor cells 
survival and CT resistance.
c-kit
Encodes a growth factor 
receptor (KIT).
Activating mutation in 
yuxtamembrane domain.
p-53
Encodes the P53 protein, 
whose regulatory protein 
is MDM2. 
Expression of P53 (or        
expression of MDM2).
CD25 IL-2 receptor subunit. 
Expressed by tumor cells.
Expression of  receptor and 
lligand      anti-tumor immune 
response modulation.
GNB1
Encodes G proteins, 
related to signal 
integration.  







pSTAT3 =     metastasis.
Expression/activation of 
JAK1 =     survival. 
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Bibliographic review on oncogenes
and tumor suppressor genes in dogs
and cats, focusing on the most
relevant/prevalent types of tumors in
each species and other important
aspects of veterinary oncology.
OBJECTIVES ACTUAL SITUATION: MOST PREVALENT NEOPLASMS 




THE HALLMARKS OF CANCER







These alterations' discovery has
generated an enormous interest and
effort to develop more individualized
novel therapeutic approaches.
Level of animal







Recent advances in the knowledge of tumor biology,




































*Oncogene (gain of function) or related to it.
*Tumor Supressor Gene (loss of function) or related to it.
FeLV FIV
• Gammaretrovirus
• Risk of lymphoma x60
• Predominant T-cells
• Lentivirus (retrovirus)
• Risk of lymphoma x5-6
• Predominant B-cells
Direct oncogenesis:
Modulation of oncogenes and
TSG’s expression by genomic
insertion.
Indirect oncogenesis:





























Diagnosis by FeLV/FIV 
tests and histological 
evaluation
Limited knowledge 











All neoplasms present the same
hallmarks (2 enabling characteristics and 8
acquired capabilities), but their aetiology can
vary hugely.
Alterations in oncogenes and TSGs
are strongly linked to some of the acquired
capabilities and they are very frequent in
animal neoplasms.
In canine mast cell tumor there have
been detected alterations in oncogenes,
TSGs and even in other genetic elements like
mtDNA.
In feline lymphoma, viral infections
stand out as potential etiologic agents, either
producing direct or indirect oncogenesis.
Even so, alterations in genetic factors have
also been reported.
Due to the great variability of
alterations that can take place, and, given
that not all of them can be treated with
traditional therapies, more and more effort is
being given to the research and
development of new, more individualized
therapeutic approaches.
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